Drug Type Small molecule drug |
Synonyms Flezelastine, D 18024, D-18024 + [2] |
Target |
Action inhibitors, antagonists |
Mechanism 5-LOX inhibitors(Arachidonate 5-lipoxygenase inhibitors), H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H31ClFN3O |
InChIKeyKBNISKYDAJMVNI-UHFFFAOYSA-N |
CAS Registry110406-33-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 2 | Germany | - | |
Asthma | Phase 2 | - | - | |
Rhinitis, Allergic | Phase 2 | - | - | |
Neoplasms | Preclinical | United States | - | - |
Neoplasms | Preclinical | Germany | - |